TLSI · NASDAQ
TriSalus Life Sciences (TLSI) Stock Price & Fundamentals
TriSalus Life Sciences (TLSI) closed at $978.53 on Oct 9, 2026, down 1.53% from the previous close of $993.71.
Share price, past year
1Y +19.87%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $978.53 |
| Sep 30, 2026 | $990.30 |
| Aug 31, 2026 | $932.80 |
| Jul 31, 2026 | $937.97 |
| Jun 30, 2026 | $930.91 |
| May 29, 2026 | $920.76 |
| Apr 30, 2026 | $839.64 |
| Mar 31, 2026 | $828.84 |
| Feb 27, 2026 | $846.63 |
| Jan 30, 2026 | $812.34 |
| Dec 31, 2025 | $821.10 |
| Nov 28, 2025 | $822.94 |
| Oct 31, 2025 | $816.71 |
Key statistics
- Market cap
- $60.15B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.31
- Revenue (TTM)
- $45.08M
- Net income (TTM)
- −$28.21M
- Shares outstanding
- 61.5M
- Dividend yield
- —
- 52-week range
- $795.38 – $994.22
TriSalus Life Sciences's market cap is $60.15B, based on a share price of $978.53 and 61.5M shares outstanding as of Jun 30, 2026.
Financials
TriSalus Life Sciences reported revenue of $45.15M for fiscal 2025, up 53.41% from fiscal 2024.
TriSalus Life Sciences reported a net loss of $39.23M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $45.15M | +53.4% | −$39.23M | −86.9% | −$1.84 | −$18.93M |
| FY2024ended Dec 31, 2024 | $29.43M | +59.0% | −$30.05M | −102.1% | −$1.31 | −$41.19M |
| FY2023ended Dec 31, 2023 | $18.51M | +49.3% | −$59.36M | −320.7% | −$6.77 | −$51.17M |
| FY2022ended Dec 31, 2022 | $12.40M | — | −$47.19M | −380.6% | −$161.55 | −$32.97M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $11.41M | −$9.19M | −$0.16 |
| Q1 FY2026ended Mar 31, 2026 | $8.90M | $1.54M | $0.03 |
| Q4 FY2025ended Dec 31, 2025 | $13.21M | −$9.75M | −$0.22 |
| Q3 FY2025ended Sep 30, 2025 | $11.57M | −$10.81M | −$0.96 |
| Q2 FY2025ended Jun 30, 2025 | $11.21M | −$8.29M | −$0.27 |
| Q1 FY2025ended Mar 31, 2025 | $9.17M | −$10.38M | −$0.39 |
| Q4 FY2024ended Dec 31, 2024 | $8.26M | −$10.11M | −$0.38 |
| Q3 FY2024ended Sep 30, 2024 | $7.35M | −$2.40M | −$0.12 |
Company profile
- Name
- TriSalus Life Sciences, Inc.
- Ticker
- TLSI
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 6272 West 91st Avenue, Westminster, CO 80031
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001826667
Recent SEC filings
- Sep 22, 2026
- Aug 6, 2026
- Aug 6, 2026
- May 14, 2026
- May 12, 2026
- May 12, 2026
- Apr 29, 2026
- Apr 7, 2026
Frequently asked questions
What is TriSalus Life Sciences's stock price?
TriSalus Life Sciences (TLSI) closed at $978.53 on Oct 9, 2026, down 1.53% from the previous close of $993.71.
What is TriSalus Life Sciences's market cap?
TriSalus Life Sciences's market cap is $60.15B, based on a share price of $978.53 and 61.5M shares outstanding as of Jun 30, 2026.
How much revenue does TriSalus Life Sciences make?
TriSalus Life Sciences reported revenue of $45.15M for fiscal 2025, up 53.41% from fiscal 2024.
Does TriSalus Life Sciences pay a dividend?
TriSalus Life Sciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from TriSalus Life Sciences, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures